Pharma / Biotech

FDA Approves First FGFR Kinase Inhibitor for Advanced Bladder Ca

The FDA granted accelerated approval to erdafitinib (Balversa, Janssen) for the treatment of adults with locally advanced or metastatic urothelial cancer with susceptible fibroblast growth factor receptor alterations that has progressed during or after platinum-containing chemotherapy.

Source link

Related posts

MUCUS RELIEF EXTENDED RELEASE (Guaifenesin) Tablet [TARGET Corporation]


BACLOFEN Tablet [Medsource Pharmaceuticals]


MARCS CHEST CONGESTION RELIEF DM (Dextromethorphan Hydrobromide / Guaifenesin) Tablet [Marc Glassman Inc]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy